轮状病毒疫苗接种在导致日本中部一起暴发的G8P[8]轮状病毒新发毒株中的作用
研究回顾性分析了2017年2月至7月日本静冈县G8P[8]轮状病毒A组暴发期间轮状病毒疫苗(RV1和RV5)的效果。80名急性胃肠炎患儿中,58名(73%)检出轮状病毒,其中53名(66%)为G8P[8]毒株。疫苗对G8P[8]轻症感染未见实质效果(VE 14%,95%CI -140%至70%),但对中症(VE 75%,95%CI 1%至40%)和重症(VE 92%,95%CI 60%至98%)仍高度有效。
要点
- G8P[8]轮状病毒暴发中,疫苗对轻症感染VE为14%(95%CI -140%至70%),无实质效果。
- 疫苗对中症轮状病毒感染VE为75%(95%CI 1%至40%),对重症VE为92%(95%CI 60%至98%)。
- 接种疫苗儿童的Vesikari评分、腹泻持续时间和频率、体温均显著低于未接种儿童。
核心结论
- 本研究表明,在由疫苗未靶向的G8P[8]轮状病毒引起的暴发中,现行轮状病毒疫苗对中度和重度感染有效,但对轻度感染无效。
研究设计与样本
- 回顾性研究,在日本静冈县2017年2月至7月G8P[8]轮状病毒暴发期间,通过PCR和序列分型确认轮状病毒感染及基因型,采用条件logistic回归调整年龄,比较PCR阳性与阴性急性胃肠炎儿童的疫苗接种状态以评估疫苗效果。
- 共纳入80名急性胃肠炎儿童,其中58名(73%)检出轮状病毒,53名(66%)为G8P[8]轮状病毒。
主要发现
- G8P[8]轮状病毒与其他轮状病毒株的临床特征严重程度相同。
- G8P[8]轮状病毒在接种疫苗儿童中的罹患率为61.1%,在未接种儿童中为65.5%,两者几乎相似。
- 对G8P[8]轮状病毒未见实质疫苗效果(VE 14%,95%CI -140%至70%),对其他轮状病毒株轻症感染VE为58%(95%CI -20%至90%)。
- 疫苗对中度轮状病毒感染VE为75%(95%CI 1%至40%),对重度感染VE为92%(95%CI 60%至98%)。
- 接种疫苗儿童的Vesikari评分、腹泻持续时间和频率、体温均显著低于未接种儿童。
关键数值与推荐
- G8P[8]轮状病毒轻症感染VE为14%(95%CI -140%至70%)。
- 其他轮状病毒株轻症感染VE为58%(95%CI -20%至90%)。
- 中度轮状病毒感染VE为75%(95%CI 1%至40%)。
- 重度轮状病毒感染VE为92%(95%CI 60%至98%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In this study, we examined the effectiveness of RV1 and RV5 vaccines during an outbreak of G8P[8] rotavirus group A strain (G8P[8]-RVA). These vaccines were originally designed to provide protection against severe diseases caused by common circulating strains, whereas G8P[8]-RVA remains emerging strain and partially heterotypic to the vaccines. It is imperative to investigate vaccine effectiveness (VE) against G8P[8]-RVA because this strain appears to be predominant in recent years, particularly, in post-vaccine era. METHODS: RVA infection and genotypes were confirmed by polymerase chain reaction (PCR) followed by sequence-based genotyping. VE was determined during an outbreak of G8P[8]-RVA in Shizuoka Prefecture, Japan, in February-July 2017, retrospectively, by comparing vaccination status of children suffering from acute gastroenteritis (AGE) between 'PCR-positive' and 'PCR-negative' cases using conditional logistic regression adjusted for age. RESULTS: Among 80 AGE children, RVA was detected in 58 (73%), of which 53 (66%) was G8P[8]-RVA. The clinical characteristics of G8P[8]-RVA and other RVA strains were identically severe. Notably, the attack rates of G8P[8]-RVA in vaccinated (61.1%) and unvaccinated (65.5%) children were almost similar. Indeed, no substantial effectiveness were found against G8P[8]-RVA (VE, 14% [95% CI: -140% to 70%]) or other RVA strains (VE, 58% [95% CI: -20% to 90%]) for mild infections. However, these vaccines remained strongly effective against moderate (VE, 75% [95% CI: 1% to 40%]) and severe (VE, 92% [95% CI: 60% to 98%]) RVA infections. The disease severity including Vesikari score, duration and frequency of diarrhea, and body temperature were significantly lower in vaccinated children. CONCLUSIONS: This study demonstrates the effectiveness of current RV vaccines against moderate and severe, but not against the mild infections during an outbreak caused by unusual G8P[8]-RVA, which was virtually not targeted in the vaccines.
引用
- Hoque SA, Kobayashi M, Takanashi S, et al. Role of rotavirus vaccination on an emerging G8P[8] rotavirus strain causing an outbreak in central Japan. Vaccine. 2017. PMID: 29183732. doi:10.1016/j.vaccine.2017.11.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。